Sharapova to make comeback after doping ban

January 10, 2017 07:40 pm | Updated 07:40 pm IST - BERLIN

Sharapova was originally banned for two years after testing positive for meldonium at last year's Australian Open.

Sharapova was originally banned for two years after testing positive for meldonium at last year's Australian Open.

Five-time grand slam champion Maria Sharapova will return to competitive action at the Stuttgart Grand Prix in April, the Russian said on Tuesday. She makes a comeback after two years, following a 15-month doping ban.

The Florida-based Sharapova was originally banned for two years after testing positive for meldonium at last year's Australian Open.

The former world number one, one of the highest paid athletes in the world in the past decade, admitted she had used meldonium for years and was not aware it had been banned since the start of 2016.

Her suspension was later cut to 15 months on appeal.

“I could not be happier to have my first match back on tour at one of my favourite tournaments,” she said.

“I can't wait to see all my great fans and to be back doing what I love.”

She will return to action in time to contest the season's second grand slam at Roland Garros. The French Open begins on May 22.

“I'm really happy for Maria that she's back after a long break. Particularly pleasing for me is that it's going to be our audience that gets to watch her comeback live,” said tournament director Markus Guenthardt.

“(It)...is certain to be one of the sporting and emotional highlights of our anniversary tournament.”

Sharapova, who will turn 30 on April 19, had earned $29.7 million in 2015 as the world's highest paid female athlete.

She had called the International Tennis Federation's (ITF) original ruling “unfairly harsh” as an independent tribunal had found that she had not intentionally violated anti-doping rules.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.